Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-09T01:38:57.055Z Has data issue: false hasContentIssue false
  • English
  • Français

Attitudes and Factors Associated With Intention to the Third Dose of COVID-19 Vaccine Among Adolescents: A Cross-Sectional Survey in 3 Provinces of China

Published online by Cambridge University Press:  27 July 2022

Taishun Li ,
Ruowen Qi ,
Yi-Hua Zhou ,
Yuqian Luo ,
Shi-Yuan Wang ,
Bingwei Chen  and
Biyun Xu Open the ORCID record for Biyun Xu [Opens in a new window]
Taishun Li
Affiliation:
Medical Statistics and Analysis Center, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
Ruowen Qi
Affiliation:
Medical Statistics and Analysis Center, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
Yi-Hua Zhou
Affiliation:
Department of Laboratory Medicine and Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
Yuqian Luo
Affiliation:
Department of Laboratory Medicine and Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
Shi-Yuan Wang
Affiliation:
School of Public Health, Southeast University, Nanjing, China
Bingwei Chen*
Affiliation:
School of Public Health, Southeast University, Nanjing, China
Biyun Xu*
Affiliation:
Medical Statistics and Analysis Center, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
*
Corresponding authors: Bingwei Chen, Email: drchenbw@seu.edu.cn; Biyun Xu, Email: biyunxu@163.com.
Corresponding authors: Bingwei Chen, Email: drchenbw@seu.edu.cn; Biyun Xu, Email: biyunxu@163.com.
Rights & Permissions [Opens in a new window]

Abstract

Objective:

The COVID-19 caused a world pandemic, posing a huge threat to global health. Widespread vaccination is the most effective way to control the pandemic. Vaccination with the third dose of the COVID-19 vaccine is currently underway. We aimed to determine the attitude of adolescents toward the third dose of COVID-19 vaccine.

Methods:

A structured questionnaire was administered between 16 August and 28 October 2021 among adolescents aged 12–17 years in three provinces of eastern region of China based on convenience sampling. The questionnaire was specifically developed to assess the adolescents’ attitude toward and willingness to accept a third dose of the COVID-19 vaccine.

Results:

In total, 94.3% (1742/1847) of the adolescents intended to accept the third dose of the COVID-19 vaccine. Age between 15–17 years, no worry about vaccine safety, confidence for vaccine effectiveness, and supporting opinion from parents were independently associated with acceptance of the third dose (p < 0.05).

Conclusions:

It is necessary for governments and school administrators to raise adolescents’ and parents’ awareness of the benefits and safety of the third dose of vaccination, which should be effective to increase the vaccination coverage among adolescents.

Keywords

COVID-19vaccinethird doseadolescentsChina

Information

Type
Research Letters
Information
Disaster Medicine and Public Health Preparedness , Volume 17 , 2023 , e201
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.

The coronavirus disease 2019 (COVID-19) has caused a world pandemic, posing a huge threat to the health of the people, the national economy, and the stability of the world. 1,Reference Ma, Liu and Liu2 By establishing higher levels of herd immunity, widespread vaccination is the most effective way to control the pandemic of COVID-19. The vaccination of COVID-19 vaccine for adolescents aged 12-17 y in China has been started since July 2021. However, the effectiveness of the vaccine against COVID-19 gradually decreases, with the waning of immunity over time. Reference Barda, Dagan and Cohen3,Reference Tré-Hardy, Cupaiolo and Wilmet4 The third vaccine dose, referred to as a booster, is proved to be effective to overcome this issue, and studies have shown that the third dose of COVID-19 vaccine is safe and effective. Reference Hause, Baggs and Gee5

Numerous factors affect the acceptance of the third dose of COVID-19 vaccine during the pandemic, especially among adolescents. This study aimed to determine the attitude and intention factors for the third dose of COVID-19 vaccine. Understanding the willingness and attitudes of adolescents toward the third dose could help policy-makers identify appropriate interventions to alleviate worries and inform public health decisions about the COVID-19 vaccination.

Methods

Study Design

A cross-sectional questionnaire was developed and distributed among adolescents aged 12-17 y in 3 provinces (Anhui, Fujian, and Jiangsu) of the eastern region of China from August 16 to October 28, 2021, and 1 senior high school and 1 junior high school in each province were selected. The protocol was approved by the Ethics Committee of the Nanjing Drum Tower Hospital (#2021-462-01). The informed consent was indicated at the beginning of the questionnaire, which was consented by the parents or guardians of the participants.

Measures

The survey consisted of questions as follows: (1) demographic information; (2) knowledge of and attitude to COVID-19 vaccine; (3) willingness to accept the third dose. The detailed questions in English of our questionnaire are provided in Supplementary File 1 (Text S1).

Statistical Analysis

Descriptive analysis of the demographics was expressed by means and standard deviations or proportions. To compare the main variables between groups, independent t-tests were performed to analyze the continuous variables, and chi-squared tests were performed to analyze the categorical variables. Multivariable logistic regression analysis was performed, including all factors showing significance (P < 0.05) in the univariate analysis, to explore the factors associated with the willingness to accept the third dose of COVID-19 vaccine. All statistical analyses were performed using the R software (R version 4.04). A P value of ≤ 0.05 was considered statistically significant.

Results

Demographic Characteristics

The survey was released to 2100 adolescents, and a total of 2048 (97.5%) responded. Of them, 202 (9.8%) who did not complete survey questionnaire were excluded. Finally, 1847 participants who completed survey questionnaire were included in this study. There were 48.2% (834/1846) males and 60.9% (1110/1822) from rural areas. Overall, 94.3% (1742/1847) adolescents intended to accept the third vaccine dose, and 5.7% (105/1847) did not. The results indicated that the acceptance willingness was associated with age (15-17 y), region (Anhui province), district (rural), and educational level (senior high school). Participants who had been quarantined or affected by COVID-19 had more intention to get vaccinated (P < 0.05). In addition to these differences, the confidence for the vaccine safety and effectiveness, and parents’ opinions did affect adolescents’ view on vaccination (P < 0.05). The detailed comparisons of the 2 groups are summarized in Table 1.

Table 1.

Demographic characteristics of the participants in the survey

*P < 0.05.

Factors Associated With the Third Dose of the COVID-19 Vaccine Acceptance

Multivariate logistic regression for willingness to take the third dose of the COVID-19 vaccine is shown in Table 2. Age between 15 and 17 y, no worry about vaccine safety, confidence for vaccine effectiveness, and supporting opinion from parents were independently associated with acceptance of the third dose (P < 0.05).

Table 2.

Factors of participants’ willingness to accept the third dose of the COVID-19 vaccine by multivariate logistic regression analysis

*P < 0.05.

Discussion

This study was conducted to investigate the willingness of adolescents at the age of 12-17 y to take the third dose of the COVID-19 vaccine. This study indicated that 94.3% (1742/1847) of participants would like to accept the third dose in the future. The main influencing factors of adolescents’ willingness to accept the third dose were age, concerns about vaccine safety and effectiveness, and parents’ opinions.

Hesitancy to receive vaccination against COVID-19 has been widely reported. Reference Alibrahim and Awad6 The main reasons for the third vaccine dose hesitancy in adolescents found in the present study were concerns about the safety and effectiveness of vaccines, which is consistent with that in other reports. Reference Montalti, Rallo and Guaraldi7,Reference Choi, Jo and Jo8 Hence, the government should focus on the public awareness of the safety and effectiveness of COVID-19 vaccines.

The results found significant associations between parents’ attitudes and COVID-19 vaccine acceptance willingness of the third dose in adolescents, which is in accordance with the previous study that focused on parents’ willingness to accept the COVID-19 vaccine for their children. Reference Catma and Reindl9 This may be due to the fact that adolescents are minors and their behavior is influenced by parents. The results also indicated that vaccinated parents were more supportive of their children getting the third vaccine dose than unvaccinated parents. Recent research reported that adolescents have the capacity to understand benefit and safety concerns about the COVID-19 vaccination, and suggested COVID-19 vaccination of minors without parental consent. Reference Morgan, Schwartz and Sisti10 In the future, public health agencies should stress the safety and effectiveness of vaccines to dismiss the parents’ concerns and improve parents’ own vaccine acceptance rate, which will promote adolescents to get the third dose.

Supplementary material

To view supplementary material for this article, please visit https://doi.org/10.1017/dmp.2022.181.

Author contributions

T.L.: conceptualization, data curation, writing the draft, and statistical analysis. R.Q., Y-H.Z., Y.L., and S-Y.W.: data curation, analysis of data, and review of the draft. B.C. and B.X.: conceptualization and critical revision of the draft.

Funding statement

This research was funded by Jiangsu Innovative and Enterpreneurial Talent Programme (Grant Number: JSSCBS20211510), and funded by Natural Science Foundation of Jiangsu Province (Grant Number: BK20190357).

Conflicts of interest

The authors report no conflict of interest.

References

Global Burden of Disease 2020 Health Financing Collaborator Network. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050. Lancet. 2021;398(10308):1317-1343. doi: 10.1016/S0140-6736(21)01258-7 CrossRefGoogle Scholar
Ma, Q, Liu, J, Liu, Q, et al. Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(12):e2137257. doi: 10.1001/jamanetworkopen.2021.37257 CrossRefGoogle ScholarPubMed
Barda, N, Dagan, N, Cohen, C, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. 2021;398(10316):2093-2100. doi: 10.1016/S0140-6736(21)02249-2 CrossRefGoogle ScholarPubMed
Tré-Hardy, M, Cupaiolo, R, Wilmet, A, et al. Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary. J Infect. 2021;83(5):559-564. doi: 10.1016/j.jinf.2021.08.031 Google ScholarPubMed
Hause, AM, Baggs, J, Gee, J, et al. Safety monitoring of an additional dose of COVID-19 vaccine - United States, August 12-September 19, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(39):1379-1384. doi: 10.15585/mmwr.mm7039e4 CrossRefGoogle Scholar
Alibrahim, J, Awad, A. COVID-19 vaccine hesitancy among the public in Kuwait: a cross-sectional survey. Int J Environ Res Public Health. 2021;18(16):8836. doi: 10.3390/ijerph18168836 CrossRefGoogle ScholarPubMed
Montalti, M, Rallo, F, Guaraldi, F, et al. Would parents get their children vaccinated against SARS-CoV-2? Rate and predictors of vaccine hesitancy according to a survey over 5000 families from Bologna, Italy. Vaccines (Basel). 2021;9(4):366. doi: 10.3390/vaccines9040366 CrossRefGoogle ScholarPubMed
Choi, SH, Jo, YH, Jo, KJ, et al. Pediatric and parents’ attitudes towards COVID-19 vaccines and intention to vaccinate for children. J Korean Med Sci. 2021;36(31):e227. doi: 10.3346/jkms.2021.36.e227 CrossRefGoogle ScholarPubMed
Catma, S, Reindl, D. Parents’ willingness to pay for a COVID-19 vaccine for themselves and their children in the United States. Hum Vaccin Immunother. 2021;17(9):2919-2925. doi: 10.1080/21645515.2021.1919453 CrossRefGoogle ScholarPubMed
Morgan, L, Schwartz, JL, Sisti, DA. COVID-19 vaccination of minors without parental consent: respecting emerging autonomy and advancing public health. JAMA Pediatr. 2021;175(10):995-996. doi: 10.1001/jamapediatrics.2021.1855 CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Demographic characteristics of the participants in the survey

Figure 1

Table 2. Factors of participants’ willingness to accept the third dose of the COVID-19 vaccine by multivariate logistic regression analysis

Supplementary material: File

Xu et al. supplementary material

Table S1

Download Xu et al. supplementary material(File)
File 45.6 KB